SCHEMBL20656759

SCHEMBL20656759

CC(C)(C=O)CO.CC(C)(CO)CO.CCOC(C)OCC

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4808596 0.94 LMNA (0.48) LMNA
SCHEMBL723007 0.84 LMNA (0.60) LMNA
SCHEMBL18229469 0.80 MEN1 (0.32)
SCHEMBL9641585 0.77 LMNA (0.38) LMNA
SCHEMBL11079148 0.77 LMNA (0.55) LMNA
SCHEMBL9421614 0.74 LMNA (0.35) LMNA
SCHEMBL11622826 0.73 MAPT (0.39) LMNA
Alcohol SCHEMBL28550441 0.73 ALDH1A1 (0.35)
SCHEMBL9186664 0.73 MEN1 (0.35)
SCHEMBL36074 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3431479-B1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON MITSUBISHI GAS CHEMICAL CO (JP) 2020-08-26 EP claimed
US-10370384-B2 Method for producing diol having cyclic acetal skeleton MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-08-06 US claimed
US-20190055259-A1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-02-21 US claimed
EP-3431479-A1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON Mitsubishi Gas Chemical Company, Inc. (JP) 2019-01-23 EP claimed
EP-3431479-B1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON MITSUBISHI GAS CHEMICAL CO (JP) 2020-08-26 EP disclosed
US-10370384-B2 Method for producing diol having cyclic acetal skeleton MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-08-06 US disclosed
US-20190055259-A1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2019-02-21 US disclosed
EP-3431479-A1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON Mitsubishi Gas Chemical Company, Inc. (JP) 2019-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370384-B2 Method for producing diol having cyclic acetal skeleton HPD, DHPS, GRHPR LMNA 2611/4885
US-20190055259-A1 METHOD FOR PRODUCING DIOL HAVING CYCLIC ACETAL SKELETON HPD, DHPS, GRHPR LMNA 2611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.